A simulation of loading doses for vancomycin continuous infusion regimens in intensive care

References

• Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adults: summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2009;29:1275–1279.
   PubMed Web of Science ®Google Scholar
• Moise-Broder PA, Forrest A, Birmingham MC, et al. 2004. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet. 43:925–942.
   PubMed Web of Science ®Google Scholar
• Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2009;49:325–327.
   PubMed Web of Science ®Google Scholar
• Men P, Li HB, Zhai SD, et al. 2016. Association between the AUC0–24/MIC ratio of vancomycin and its clinical effectiveness: a systematic review and meta-analysis. PLoS One. 11:e0146224.
   PubMed Web of Science ®Google Scholar
• Saugel B, Nowack MC, Hapfelmeier A, et al. Continuous intravenous administration of vancomycin in medical intensive care unit patients. J Crit Care. 2013;28:9–13.
   PubMed Web of Science ®Google Scholar
• Spadaro S, Berselli A, Fogagnolo A, et al. Evaluation of a protocol for vancomycin administration in critically patients with and without kidney dysfunction. BMC Anesthesiol. 2015;15:95.
   PubMed Web of Science ®Google Scholar
• Wysocki M, Delatour F, Faurisson F, et al. Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study. Antimicrob Agents Chemother. 2001;45:2460–2467.
   PubMed Web of Science ®Google Scholar
• Cristallini S, Hites M, Kabtouri H, et al. A new regimen for continuous infusion of vancomycin in critically ill patients. Antimicrob Agents Chemother. 2016;60:4750–4756.
   PubMed Web of Science ®Google Scholar
• Holmes NE, Turnidge JD, Munckhof WJ, et al. 2013. Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 57:1654–1663.
   PubMed Web of Science ®Google Scholar
• Neely MN, Youn G, Jones B, et al. 2014. Are vancomycin trough concentrations adequate for optimal dosing? Antimicrob Agents Chemother. 58:309–316.
   PubMed Web of Science ®Google Scholar
• Waineo MF, Kuhn TC, Brown DL. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion. J Clin Pharm Ther. 2015;40:259–265.
   PubMed Web of Science ®Google Scholar
• Man SS, Carr RR, Ensom MH. Comparison of continuous and intermittent iv infusion of vancomycin: systematic review. Can J Hosp Pharm. 2010;63:373–381.
   PubMedGoogle Scholar
• Leekha S, Terrell CL, Edson RS. General principles of antimicrobial therapy. Mayo Clin Proc. 2011;86:156–167.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Bassetti M, François B, et al. Advances in antibiotic therapy in the critically ill. Crit Care. 2016;20:133.
   PubMed Web of Science ®Google Scholar
• Lodise TP, McKinnon PS, Swiderski L, et al. 2003. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis. 36:1418–1423.
   PubMed Web of Science ®Google Scholar
• Wang JT, Fang CT, Chen YC, et al. 2001. Necessity of a loading dose when using vancomycin in critically ill patients. J Antimicrob Chemother. 47:246.
   PubMed Web of Science ®Google Scholar
• Mohammedi I, Descloux E, Argaud L, et al. Loading dose of vancomycin in critically ill patients: 15 mg/kg is a better choice than 500 mg. Int J Antimicrob Agents. 2006;27:259–262.
   PubMed Web of Science ®Google Scholar
• Truong J, Levkovich BJ, Padiglione AA. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels. Intern Med J. 2012;42:23–29.
   PubMed Web of Science ®Google Scholar
• Vuagnat A, Stern R, Lotthe A, et al. High dose vancomycin for osteomyelitis: continuous vs. Intermittent infusion. J Clin Pharm Ther. 2004;29:351–357.
   PubMed Web of Science ®Google Scholar
• Hutschala D, Kinstner C, Skhirdladze K, et al. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion. Anesthesiology. 2009;111:356–365.
   PubMed Web of Science ®Google Scholar
• Wada DR, Drover DR, Lemmens HJ. 1998. Determination of the distribution volume that can be used to calculate the intravenous loading dose. Clin Pharmacokinet. 35:1–7.
   PubMed Web of Science ®Google Scholar
• Boucher BA, Wood GC, Swanson JM. Pharmacokinetic changes in critical illness. Crit Care Clin. 2006;22:255–271.
   PubMed Web of Science ®Google Scholar
• Pan SD, Zhu LL, Chen M, et al. 2016. Weight-based dosing in medication use: what should we know? Patient Prefer Adherence. 10:549–560.
   PubMed Web of Science ®Google Scholar
• Pai MP. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults. Pharmacotherapy. 2012;32:856–868.
   PubMed Web of Science ®Google Scholar
• Green B, Duffull SB. 2004. What is the best size descriptor to use for pharmacokinetic studies in the obese? Br J Clin Pharmacol. 58:119–133.
   PubMed Web of Science ®Google Scholar
• Bauer LA, Edwards WA, Dellinger EP, et al. Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients. Eur J Clin Pharmacol. 1983;24:643–647.
   PubMed Web of Science ®Google Scholar
• Bonett DG, Price RM. Statistical inference for a linear function of medians: confidence intervals, hypothesis testing, and sample size requirements. Psychol Methods. 2002;7:370–383.
   PubMed Web of Science ®Google Scholar
• Alobaid AS, Hites M, Lipman J, et al. Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: a structured review. Int J Antimicrob Agents. 2016;47:259–268.
   PubMed Web of Science ®Google Scholar
• Thomas LW. The chemical composition of adipose tissue of man and mice. Q J Exp Physiol Cogn Med Sci. 1962;47:179–188.
   PubMedGoogle Scholar
• Wurtz R, Itokazu G, Rodvold K. Antimicrobial dosing in obese patients. Clin Infect Dis. 1997;25:112–118.
   PubMed Web of Science ®Google Scholar
• Roberts JA, Taccone FS, Udy AA, et al. 2011. Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens. Antimicrob Agents Chemother. 55:2704–2709.
   PubMed Web of Science ®Google Scholar
• Matzke GR, McGory RW, Halstenson CE, et al. Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother. 1984;25:433–437.
   PubMed Web of Science ®Google Scholar
• Rotschafer JC, Crossley K, Zaske DE, et al. Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations. Antimicrob Agents Chemother. 1982;22:391–394.
   PubMed Web of Science ®Google Scholar